The company reports its financial results in accordance with accounting principles generally accepted in the United States (“GAAP” or referred to herein as “reported”). To supplement our consolidated financial statements reported on a GAAP basis, we provide the following non-GAAP financial measures: “comparable net revenues,” “comparable currency neutral net revenues,” “organic revenues,” “comparable operating margin,” “underlying operating margin,” “comparable operating income,” “comparable currency neutral operating income,” “comparable EPS,” “comparable currency neutral EPS,” “comparable currency neutral EPS excluding acquisitions and divestitures,” “underlying effective tax rate,” “free cash flow,” “free cash flow excluding the fairlife contingent consideration payment” and “net share repurchases” each of which is defined below. Management believes these non-GAAP financial measures provide investors with additional meaningful financial information that should be considered when assessing our underlying business performance and trends. Further, management believes these non-GAAP financial measures also enhance investors’ ability to compare period-to-period financial results. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the company’s reported results prepared in accordance with GAAP. Our non-GAAP financial measures do not represent a comprehensive basis of accounting. Therefore, our non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies. Reconciliations of each of these non-GAAP financial measures to GAAP information are also included below. Management uses these non-GAAP financial measures in making financial, operating, compensation and planning decisions and in evaluating the company’s performance. Disclosing these non- GAAP financial measures allows investors and management to view our operating results excluding the impact of items that are not reflective of the underlying operating performance. DEFINITIONS • “Currency neutral operating results” are determined by dividing or multiplying, as appropriate, our current period actual U.S. dollar operating results by the current period actual exchange rates (that include the impact of current period currency hedging activities) to derive our current period local currency operating results. We then multiply or divide, as appropriate, the derived current period local currency operating results by the foreign currency exchange rates (that also include the impact of the comparable prior period currency hedging activities) used to translate the company’s financial statements in the comparable prior year period to determine what the current period U.S. dollar operating results would have been if the foreign currency exchange rates had not changed from the comparable prior year period. • “Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the company considers to be structural changes. The impact of acquisitions and divestitures is the difference between the change in the relevant metric and the change in what that metric would have been if we removed the amount associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a component of acquisitions and divestitures and also include the impact of intercompany transactions between our operating segments, as applicable. Typically, structural changes do not impact the company’s unit case volume on a consolidated basis or at the geographic operating segment level. In January, February and December 2024 as well as May 2025, the company refranchised our bottling operations in certain territories in India, and in February 2024, the company refranchised our bottling operations in Bangladesh and the Philippines. The impact of each of these refranchisings has been included as a structural change in our analysis of net revenues on a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments for the three months and year ended December 31, 2025, as applicable. Additionally, in October 2025, the company sold our finished product operations in Nigeria. The impact of this sale has been included as a divestiture in our analysis of net revenues on a consolidated basis as well as for the EMEA operating segment for the three months and year ended December 31, 2025. • “Comparable net revenues” is a non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed further below). “Comparable currency neutral net revenues” is a non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed further below) as well as the impact of fluctuations in foreign currency exchange rates. Management believes the comparable net revenues (non-GAAP) growth measure and the comparable currency neutral net revenues (non-GAAP) growth measure provide investors with useful supplemental information to enhance their understanding of the company’s revenue performance and trends by improving their ability to compare our period- to-period results. “Organic revenues” is a non-GAAP financial measure that excludes or has otherwise been THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures 15 -- 1 of 15 -- adjusted for the impact of acquisitions and divestitures, as applicable, and the impact of fluctuations in foreign currency exchange rates. Management believes the organic revenue (non-GAAP) growth measure provides users with useful supplemental information regarding the company’s ongoing revenue performance and trends by presenting revenue growth excluding the impact of foreign exchange as well as the impact of acquisitions and divestitures. • “Comparable operating income” is a non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed further below). “Comparable currency neutral operating income” is a non- GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed further below) and the impact of fluctuations in foreign currency exchange rates. “Comparable operating margin” is a non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed further below). “Underlying operating margin” is a non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed further below), the impact of fluctuations in foreign currency exchange rates, and the impact of acquisitions and divestitures, as applicable. Management uses these non-GAAP financial measures to evaluate the company’s performance and make resource allocation decisions. Further, management believes the comparable operating income (non-GAAP) growth measure, comparable currency neutral operating income (non-GAAP) growth measure, comparable operating margin (non- GAAP) measure and underlying operating margin (non-GAAP) measure enhance its ability to communicate the underlying operating results and provide investors with useful supplemental information to enhance their understanding of the company’s underlying business performance and trends by improving their ability to compare our period-to-period financial results. • “Comparable EPS,” “comparable currency neutral EPS” and “comparable currency neutral EPS excluding acquisitions and divestitures” are non-GAAP financial measures that exclude or have otherwise been adjusted for items impacting comparability (discussed further below). Comparable currency neutral EPS (non-GAAP) has been adjusted for the impact of fluctuations in foreign currency exchange rates, and comparable currency neutral EPS excluding acquisitions and divestitures (non-GAAP) has been adjusted for the impact of fluctuations in foreign currency exchange rates and the impact of acquisitions and divestitures, as applicable. Management uses these non-GAAP financial measures to evaluate the company’s performance and make resource allocation decisions. Further, management believes the comparable EPS (non-GAAP), comparable currency neutral EPS (non-GAAP) and comparable currency neutral EPS excluding acquisitions and divestitures (non-GAAP) growth measures enhance its ability to communicate the underlying operating results and provide investors with useful supplemental information to enhance their understanding of the company’s underlying business performance and trends by improving their ability to compare our period-to-period financial results. • “Underlying effective tax rate” is a non-GAAP financial measure that represents the estimated annual effective income tax rate on income before income taxes, which excludes or has otherwise been adjusted for items impacting comparability (discussed further below). • "Net share repurchases” is a non-GAAP financial measure that reflects the net amount of purchases of stock for treasury after considering proceeds from the issuances of stock and, as applicable, the net change in stock issuance receivables (related to employee stock options exercised but not settled prior to the end of the period) and the net change in treasury stock payables (for treasury shares repurchased but not settled prior to the end of the period). • “Free cash flow” is a non-GAAP financial measure that represents net cash provided by operating activities less purchases of property, plant and equipment. “Free cash flow excluding the fairlife contingent consideration payment” is a non-GAAP financial measure that represents net cash provided by operating activities less purchases of property, plant and equipment and excludes the fairlife contingent consideration payment that was made in March 2025. Management uses these non-GAAP financial measures to evaluate the company’s performance and make resource allocation decisions. ITEMS IMPACTING COMPARABILITY The following information is provided to give qualitative and quantitative information related to items impacting comparability. Items impacting comparability are not defined terms within GAAP. Therefore, our non-GAAP financial THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures 16 -- 2 of 15 -- information may not be comparable to similarly titled measures reported by other companies. We determine which items to consider as “items impacting comparability” based on how management views our business; makes financial, operating, compensation and planning decisions; and evaluates the company’s ongoing performance. Items such as charges, gains and accounting changes which are viewed by management as impacting only the current period or the comparable period, but not both, or as pertaining to different and unrelated underlying activities or events across comparable periods, are generally considered “items impacting comparability.” Items impacting comparability include, but are not limited to, asset impairments, transaction gains/losses including associated costs, and charges related to restructuring initiatives, in each case when exceeding a U.S. dollar threshold. Also included are our proportionate share of similar items incurred by our equity method investees, timing differences related to our economic (non-designated) hedging activities, and timing differences related to unrealized mark-to-market adjustments of equity securities and trading debt securities, regardless of size. In addition, we provide the impact that fluctuations in foreign currency exchange rates had on our financial results (“currency neutral operating results” defined above). Asset Impairments During the three months and year ended December 31, 2025, the company recorded a charge of $960 million related to the impairment of our BODYARMOR trademark, which was primarily driven by revised projections of future operating results, including a slowing of the projected long-term growth rate for the category, an intensifying competitive environment, and more focused innovation and international rollout plans. Additionally, the company recorded charges of $13 million and $44 million, respectively, related to the impairment of a trademark in Latin America, which was primarily driven by revised projections of future operating results and changes in macroeconomic conditions. The company also recorded a charge of $41 million related to the impairment of a trademark and property, plant and equipment in Asia Pacific, which was primarily driven by revised projections of future operating results. During the year ended December 31, 2025, the company recorded an other-than-temporary impairment charge of $40 million related to an equity method investee in Latin America, which was primarily driven by revised projections of future operating results. Additionally, the company recorded an other-than-temporary impairment charge of $25 million in Latin America, primarily driven by the restructuring of a joint venture. During the three months and year ended December 31, 2024, the company recorded charges of $39 million and $126 million, respectively, related to the impairment of a trademark in Latin America, which was primarily driven by revised projections of future operating results and changes in macroeconomic conditions. During the year ended December 31, 2024, the company recorded a charge of $760 million related to the impairment of our BODYARMOR trademark, which was primarily driven by revised projections of future operating results and higher discount rates resulting from changes in macroeconomic conditions since the acquisition date. Additionally, the company recorded an other-than-temporary impairment charge of $34 million related to an equity method investee in Latin America. Equity Investees During the year ended December 31, 2025, the company recorded a net charge of $21 million. During the three months and year ended December 31, 2024, the company recorded net charges of $47 million and $92 million, respectively. These amounts represent the company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Transaction Gains/Losses During the three months and year ended December 31, 2025, the company recorded a gain of $1,952 million related to the sale of our ownership interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an equity method investee, to Coke Consolidated and a gain of $31 million related to the substantial liquidation of a joint venture in China. The company also recorded a charge of $1,274 million related to our bottling operations in Africa that became held for sale, primarily due to the negative net foreign currency translation adjustments that will be reclassified to income upon sale. Additionally, the company incurred charges of $5 million and $12 million, respectively, of transactions costs related to our divestiture activities. THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures 17 -- 3 of 15 -- During the year ended December 31, 2025, the company recorded a gain of $331 million related to the sale of a portion of our ownership interest in Coca-Cola Europacific Partners plc, an equity method investee. The company also recognized a gain of $102 million related to the refranchising of our bottling operations in certain territories in India. Additionally, the company recorded a charge of $393 million related to the sale of our finished product operations in Nigeria and a charge of $36 million related to the refranchising of certain bottling operations in Ghana. The company also recorded a charge of $47 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife. In March 2025, the company made the remaining milestone payment for fairlife. During the three months and year ended December 31, 2024, the company recorded charges of $88 million and $3,109 million, respectively, related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife. During the three months and year ended December 31, 2024, the company recorded gains of $13 million and $303 million, respectively, related to the refranchising of our bottling operations in certain territories in India. During the year ended December 31, 2024, the company recorded a gain of $595 million related to the refranchising of our bottling operations in the Philippines. Additionally, the company recorded a gain of $506 million related to the sale of our ownership interest in an equity method investee in Thailand and a gain of $338 million related to the sale of a portion of our ownership interest in Coke Consolidated to Coke Consolidated. The company also recorded transactions costs related to our divestiture activities of $9 million. During the year ended December 31, 2024, the company recorded a gain of $6 million related to the sale of our ownership interest in one of our equity method investees in Latin America and recorded a loss of $7 million related to post-closing adjustments for the refranchising of our bottling operations in Vietnam in 2023. Restructuring During the three months and year ended December 31, 2025, the company recorded charges of $34 million and $97 million, respectively. During the three months and year ended December 31, 2024, the company recorded charges of $31 million and $133 million, respectively. The costs incurred were primarily related to certain initiatives designed to further simplify and standardize our organization as part of our productivity and reinvestment program. Other Items Economic (Non-Designated) Hedges The company uses derivatives as economic hedges primarily to mitigate the foreign exchange risk for certain currencies, certain interest rate risk, and the price risk associated with the purchase of materials used in our manufacturing processes as well as the purchase of vehicle fuel. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic hedges. The changes in fair values of these economic hedges are immediately recognized in earnings. The company excludes the net impact of mark-to-market adjustments for outstanding hedges and realized gains/losses for settled hedges from our non-GAAP financial information until the period in which the underlying exposure being hedged impacts our consolidated statement of income. Management believes this adjustment provides meaningful information related to the impact of our economic hedging activities. During the three months and year ended December 31, 2025, the net impact of the company’s adjustment related to our economic hedging activities resulted in decreases of $19 million and $36 million, respectively, to our non-GAAP income before income taxes. During the three months and year ended December 31, 2024, the net impact of the company’s adjustment related to our economic hedging activities resulted in decreases of $162 million and $138 million, respectively, to our non-GAAP income before income taxes. THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures 18 -- 4 of 15 -- Unrealized Gains and Losses on Equity and Trading Debt Securities The company excludes the net impact of unrealized gains and losses resulting from mark-to-market adjustments on our equity and trading debt securities from our non-GAAP financial information until the period in which the underlying securities are sold and the associated gains or losses are realized, unless individually significant. Management believes this adjustment provides meaningful information related to the impact of our investments in equity and trading debt securities. During the three months and year ended December 31, 2025, the net impact of the company’s adjustment related to unrealized gains and losses on our equity and trading debt securities resulted in decreases of $85 million and $268 million, respectively, to our non-GAAP income before income taxes. During the three months and year ended December 31, 2024, the net impact of the company’s adjustment related to unrealized gains and losses on our equity and trading debt securities resulted in an increase of $58 million and a decrease of $206 million, respectively, to our non-GAAP income before income taxes. Other During the three months and year ended December 31, 2025, the company recorded charges of $4 million and $15 million, respectively, for the amortization of noncompete agreements related to the BODYARMOR acquisition in 2021. The company also recorded net charges of $2 million and $10 million, respectively, related to tax litigation expense. During the year ended December 31, 2025, the company recorded a charge of $35 million related to an indemnification agreement entered into as a part of the refranchising of certain bottling operations. Additionally, the company recorded a net charge of $2 million related to restructuring our manufacturing operations in the United States and a charge of $36 million related to non-U.S. pension curtailment and special termination benefits. During the three months and year ended December 31, 2024, the company recorded net charges of $2 million and $19 million, respectively, related to restructuring our manufacturing operations in the United States. Additionally, the company recorded charges of $4 million and $15 million, respectively, for the amortization of noncompete agreements related to the BODYARMOR acquisition. During the three months ended December 31, 2024, the company recorded a net charge of $1 million due to tax litigation expense and during the year ended December 31, 2024, the company recorded a net benefit of $2 million related to a revision of management’s estimates for tax litigation expense. During the three months and year ended December 31, 2024, the company recorded a charge of $13 million related to an indemnification agreement entered into as a part of the refranchising of certain bottling operations. Certain Tax Matters During the three months and year ended December 31, 2025, the company recorded net income tax benefits of $279 million and $851 million, respectively, primarily associated with tax benefits related to completed and pending divestitures; net changes to our unrecognized tax benefits, including interest and penalties; return to provision adjustments; and various other discrete tax items. Additionally, the company recorded $2 million and $27 million, respectively, of excess tax benefits associated with the company's stock-based compensation arrangements. During the three months and year ended December 31, 2024, the company recorded $1 million and $62 million, respectively, of excess tax benefits associated with the company’s stock-based compensation arrangements and net income tax expense of $17 million and $50 million, respectively, primarily associated with return to provision adjustments. The company also recorded net income tax expense of $39 million and a net income tax benefit of $2 million, respectively, for changes to our uncertain tax positions, including interest and penalties, as well as for various discrete tax items. Additionally, the company recorded net income tax expense of $19 million and $103 million, respectively, related to the resolution of certain foreign tax matters and recorded expense of $2 million and $24 million, respectively, for other costs directly related to those matters. During the three months and year ended December 31, 2024, the company also recorded net income tax expense of $15 million related to U.S. regulations issued during the year. THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures 19 -- 5 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions except per share data) Three Months Ended December 31, 2025 Net operating revenues Cost of goods sold Gross profit Gross margin Selling, general and administrative expenses Other operating charges Operating income Operating margin Reported (GAAP) $ 11,822 $ 4,723 $ 7,099 60.0% $ 4,199 $ 1,059 $ 1,841 15.6% Items Impacting Comparability: Asset Impairments — — — — (1,014) 1,014 Equity Investees — — — — — — Transaction Gains/Losses — — — — (5) 5 Restructuring — — — — (34) 34 Other Items (5) 7 (12) — (6) (6) Certain Tax Matters — — — — — — Comparable (Non-GAAP) $ 11,817 $ 4,730 $ 7,087 60.0% $ 4,199 $ — $ 2,888 24.4% Three Months Ended December 31, 2024 Net operating revenues Cost of goods sold Gross profit Gross margin Selling, general and administrative expenses Other operating charges Operating income Operating margin Reported (GAAP) $ 11,544 $ 4,613 $ 6,931 60.0% $ 4,046 $ 176 $ 2,709 23.5% Items Impacting Comparability: Asset Impairments — — — — (39) 39 Equity Investees — — — — — — Transaction Gains/Losses — — — — (88) 88 Restructuring — — — — (31) 31 Other Items (140) 13 (153) — (18) (135) Certain Tax Matters — — — (2) — 2 Comparable (Non-GAAP) $ 11,404 $ 4,626 $ 6,778 59.4% $ 4,044 $ — $ 2,734 24.0% Net operating revenues Cost of goods sold Gross profit Selling, general and administrative expenses Other operating charges Operating income % Change — Reported (GAAP) 2 2 2 4 502 (32) % Currency Impact (2) 2 (4) 2 — (13) % Change — Currency Neutral (Non-GAAP) 4 0 6 2 — (19) % Change — Comparable (Non-GAAP) 4 2 5 4 — 6 % Comparable Currency Impact (Non-GAAP) 0 2 (2) 2 — (8) % Change — Comparable Currency Neutral (Non-GAAP) 4 0 7 2 — 13 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 20 -- 6 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions except per share data) Three Months Ended December 31, 2025 Interest expense Equity income (loss) — net Other income (loss) — net Income before income taxes Income taxes1 Effective tax rate Net income3 Diluted net income per share Reported (GAAP) $ 431 $ 475 $ 844 $ 2,962 $ 646 21.8% $ 2,271 $ 0.53 Items Impacting Comparability: Asset Impairments — — — 1,014 235 779 0.18 Equity Investees — — — — 1 (1) — Transaction Gains/Losses — — (709) (704) (503) (201) (0.05) Restructuring — — — 34 8 26 0.01 Other Items 7 — (85) (98) (21) (77) (0.02) Certain Tax Matters — — — — 281 (281) (0.07) Comparable (Non-GAAP) $ 438 $ 475 $ 50 $ 3,208 $ 647 20.2% 2 $ 2,516 $ 0.58 Three Months Ended December 31, 2024 Interest expense Equity income (loss) — net Other income (loss) — net Income before income taxes Income taxes1 Effective tax rate Net income3 Diluted net income per share Reported (GAAP) $ 431 $ 338 $ (14) $ 2,806 $ 593 21.1% $ 2,195 $ 0.51 Items Impacting Comparability: Asset Impairments — — — 39 10 29 0.01 Equity Investees — 47 — 47 — 47 0.01 Transaction Gains/Losses — — (13) 75 19 56 0.01 Restructuring — — — 31 7 24 0.01 Other Items 7 — 58 (84) (23) (61) (0.01) Certain Tax Matters — — — 2 (89) 91 0.02 Comparable (Non-GAAP) $ 438 $ 385 $ 31 $ 2,916 $ 517 17.7% $ 2,381 $ 0.55 Interest expense Equity income (loss) — net Other income (loss) — net Income before income taxes Income taxes1 Net income3 Diluted net income per share % Change — Reported (GAAP) 0 40 — 6 9 3 4 % Change — Comparable (Non-GAAP) 0 23 60 10 25 6 6 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 1 The income tax adjustments are the calculated income tax benefits (charges) at the applicable tax rate for each of the items impacting comparability with the exception of certain tax matters discussed above. 2 This does not include the impact of the ongoing tax litigation with the U.S. Internal Revenue Service, if the company were not to prevail. 3 This represents net income attributable to shareowners of The Coca-Cola Company. 21 -- 7 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions except per share data) Year Ended December 31, 2025 Net operating revenues Cost of goods sold Gross profit Gross margin Selling, general and administrative expenses Other operating charges Operating income Operating margin Reported (GAAP) $ 47,941 $ 18,397 $ 29,544 61.6% $ 14,521 $ 1,261 $ 13,762 28.7% Items Impacting Comparability: Asset Impairments — — — — (1,045) 1,045 Equity Investees — — — — — — Transaction Gains/Losses — — — — (59) 59 Restructuring — — — — (97) 97 Other Items 121 131 (10) — (60) 50 Certain Tax Matters — — — — — — Comparable (Non-GAAP) $ 48,062 $ 18,528 $ 29,534 61.5% $ 14,521 $ — $ 15,013 31.2% Year Ended December 31, 2024 Net operating revenues Cost of goods sold Gross profit Gross margin Selling, general and administrative expenses Other operating charges Operating income Operating margin Reported (GAAP) $ 47,061 $ 18,324 $ 28,737 61.1% $ 14,582 $ 4,163 $ 9,992 21.2% Items Impacting Comparability: Asset Impairments — — — — (886) 886 Equity Investees — — — — — — Transaction Gains/Losses — — — — (3,118) 3,118 Restructuring — — — — (133) 133 Other Items (164) (70) (94) — (26) (68) Certain Tax Matters — — — (24) — 24 Comparable (Non-GAAP) $ 46,897 $ 18,254 $ 28,643 61.1% $ 14,558 $ — $ 14,085 30.0% Net operating revenues Cost of goods sold Gross profit Selling, general and administrative expenses Other operating charges Operating income % Change — Reported (GAAP) 2 0 3 0 (70) 38 % Currency Impact (2) 1 (4) 0 — (12) % Change — Currency Neutral (Non-GAAP) 4 0 7 0 — 50 % Change — Comparable (Non-GAAP) 2 1 3 0 — 7 % Comparable Currency Impact (Non-GAAP) (2) 1 (3) 0 — (7) % Change — Comparable Currency Neutral (Non-GAAP) 4 1 6 0 — 13 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 22 -- 8 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions except per share data) Year Ended December 31, 2025 Interest expense Equity income (loss) — net Other income (loss) — net Income before income taxes Income taxes1 Effective tax rate Net income3 Diluted net income per share Reported (GAAP) $ 1,654 $ 2,031 $ 1,073 $ 15,998 $ 2,861 17.9% $ 13,107 $ 3.04 Items Impacting Comparability: Asset Impairments — — 65 1,110 243 867 0.20 Equity Investees — 21 — 21 3 18 — Transaction Gains/Losses — — (713) (654) (595) (66) (0.02) Restructuring — — — 97 24 73 0.02 Other Items 25 — (231) (206) (43) (163) (0.04) Certain Tax Matters — — — — 878 (878) (0.20) Comparable (Non-GAAP) $ 1,679 $ 2,052 $ 194 $ 16,366 $ 3,371 20.6% 2 $ 12,958 $ 3.00 Year Ended December 31, 2024 Interest expense Equity income (loss) — net Other income (loss) — net Income before income taxes Income taxes1 Effective tax rate Net income3 Diluted net income per share Reported (GAAP) $ 1,656 $ 1,770 $ 1,992 $ 13,086 $ 2,437 18.6% $ 10,631 $ 2.46 Items Impacting Comparability: Asset Impairments — — 34 920 222 698 0.16 Equity Investees — 92 — 92 2 90 0.02 Transaction Gains/Losses — — (1,741) 1,377 332 1,045 0.24 Restructuring — — — 133 33 100 0.02 Other Items 25 — (206) (299) (70) (229) (0.05) Certain Tax Matters — — — 24 (104) 128 0.03 Comparable (Non-GAAP) $ 1,681 $ 1,862 $ 79 $ 15,333 $ 2,852 18.6% $ 12,463 $ 2.88 Interest expense Equity income (loss) — net Other income (loss) — net Income before income taxes Income taxes1 Net income3 Diluted net income per share % Change — Reported (GAAP) 0 15 (46) 22 17 23 23 % Change — Comparable (Non-GAAP) 0 10 145 7 18 4 4 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 1 The income tax adjustments are the calculated income tax benefits (charges) at the applicable tax rate for each of the items impacting comparability with the exception of certain tax matters discussed above. 2 This does not include the impact of the ongoing tax litigation with the U.S. Internal Revenue Service, if the company were not to prevail. 3 This represents net income attributable to shareowners of The Coca-Cola Company. 23 -- 9 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures Diluted Net Income Per Share: Three Months Ended December 31, 2025 % Change — Reported (GAAP) 4 % Currency Impact (9) % Change — Currency Neutral (Non-GAAP) 12 % Impact of Items Impacting Comparability (Non-GAAP) (2) % Change — Comparable (Non-GAAP) 6 % Comparable Currency Impact (Non-GAAP) (5) % Change — Comparable Currency Neutral (Non-GAAP) 11 Year Ended December 31, 2025 % Change — Reported (GAAP) 23 % Currency Impact (8) % Change — Currency Neutral (Non-GAAP) 32 % Impact of Items Impacting Comparability (Non-GAAP) 19 % Change — Comparable (Non-GAAP) 4 % Comparable Currency Impact (Non-GAAP) (5) % Change — Comparable Currency Neutral (Non-GAAP) 9 Note: Certain columns may not add due to rounding. 24 -- 10 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions) Net Operating Revenues by Operating Segment and Corporate: Three Months Ended December 31, 2025 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Eliminations Consolidated Reported (GAAP) $ 2,684 $ 1,697 $ 4,943 $ 1,139 $ 1,515 $ 45 $ (201) $ 11,822 Items Impacting Comparability: Other Items 1 (17) 3 8 — — — (5) Comparable (Non-GAAP) $ 2,685 $ 1,680 $ 4,946 $ 1,147 $ 1,515 $ 45 $ (201) $ 11,817 Three Months Ended December 31, 2024 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Eliminations Consolidated Reported (GAAP) $ 2,571 $ 1,647 $ 4,731 $ 1,229 $ 1,551 $ 23 $ (208) $ 11,544 Items Impacting Comparability: Other Items (30) (26) (14) (70) — — — (140) Comparable (Non-GAAP) $ 2,541 $ 1,621 $ 4,717 $ 1,159 $ 1,551 $ 23 $ (208) $ 11,404 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Eliminations Consolidated % Change — Reported (GAAP) 4 3 4 (7) (2) 94 3 2 % Currency Impact 2 (7) 0 (8) 0 2 — (2) % Change — Currency Neutral (Non-GAAP) 3 10 5 0 (2) 92 — 4 % Acquisitions, Divestitures and Structural Changes (3) 0 0 0 (2) 0 — (1) % Change — Organic Revenues (Non-GAAP) 6 10 5 0 (1) 92 — 5 % Change — Comparable (Non-GAAP) 6 4 5 (1) (2) 94 — 4 % Comparable Currency Impact (Non-GAAP) 3 (7) 0 (1) 0 2 — 0 % Change — Comparable Currency Neutral (Non- GAAP) 3 10 5 0 (2) 92 — 4 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 25 -- 11 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions) Net Operating Revenues by Operating Segment and Corporate: Year Ended December 31, 2025 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Eliminations Consolidated Reported (GAAP) $ 11,513 $ 6,334 $ 19,586 $ 5,638 $ 5,735 $ 144 $ (1,009) $ 47,941 Items Impacting Comparability: Other Items 35 45 13 28 — — — 121 Comparable (Non-GAAP) $ 11,548 $ 6,379 $ 19,599 $ 5,666 $ 5,735 $ 144 $ (1,009) $ 48,062 Year Ended December 31, 2024 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Eliminations Consolidated Reported (GAAP) $ 10,958 $ 6,471 $ 18,869 $ 5,594 $ 6,223 $ 110 $ (1,164) $ 47,061 Items Impacting Comparability: Other Items (46) (46) (14) (58) — — — (164) Comparable (Non-GAAP) $ 10,912 $ 6,425 $ 18,855 $ 5,536 $ 6,223 $ 110 $ (1,164) $ 46,897 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Eliminations Consolidated % Change — Reported (GAAP) 5 (2) 4 1 (8) 30 13 2 % Currency Impact 0 (12) 0 (3) (2) 0 — (2) % Change — Currency Neutral (Non-GAAP) 5 10 4 3 (5) 30 — 4 % Acquisitions, Divestitures and Structural Changes (1) 0 0 (1) (7) 0 — (1) % Change — Organic Revenues (Non-GAAP) 6 10 4 5 1 30 — 5 % Change — Comparable (Non-GAAP) 6 (1) 4 2 (8) 30 — 2 % Comparable Currency Impact (Non-GAAP) 1 (11) 0 (1) (2) 0 — (2) % Change — Comparable Currency Neutral (Non- GAAP) 5 10 4 4 (5) 30 — 4 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 26 -- 12 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions) Operating Income (Loss) by Operating Segment and Corporate: Three Months Ended December 31, 2025 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Consolidated Reported (GAAP) $ 811 $ 984 $ 427 $ 250 $ 191 $ (822) $ 1,841 Items Impacting Comparability: Asset Impairments — 13 960 41 — — 1,014 Transaction Gains/Losses — — — — — 5 5 Restructuring — — — — — 34 34 Other Items 1 (17) (5) 8 1 6 (6) Certain Tax Matters — — — — — — — Comparable (Non-GAAP) $ 812 $ 980 $ 1,382 $ 299 $ 192 $ (777) $ 2,888 Three Months Ended December 31, 2024 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Consolidated Reported (GAAP) $ 895 $ 989 $ 1,227 $ 391 $ 199 $ (992) $ 2,709 Items Impacting Comparability: Asset Impairments — 39 — — — — 39 Transaction Gains/Losses — — — — — 88 88 Restructuring — — — — — 31 31 Other Items (34) (26) (27) (70) 3 19 (135) Certain Tax Matters 2 — — — — — 2 Comparable (Non-GAAP) $ 863 $ 1,002 $ 1,200 $ 321 $ 202 $ (854) $ 2,734 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Consolidated % Change — Reported (GAAP) (9) 0 (65) (36) (4) 17 (32) % Currency Impact (7) (16) (2) (22) (3) (1) (13) % Change — Currency Neutral (Non-GAAP) (2) 15 (64) (15) (1) 18 (19) % Impact of Items Impacting Comparability (Non-GAAP) (3) 2 (80) (29) 1 8 (38) % Change — Comparable (Non-GAAP) (6) (2) 15 (7) (5) 9 6 % Comparable Currency Impact (Non-GAAP) (4) (15) 0 (4) (3) (1) (8) % Change — Comparable Currency Neutral (Non-GAAP) (2) 13 15 (3) (2) 10 13 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 27 -- 13 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures (In millions) Operating Income (Loss) by Operating Segment and Corporate: Year Ended December 31, 2025 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Consolidated Reported (GAAP) $ 4,298 $ 3,742 $ 5,070 $ 2,042 $ 426 $ (1,816) $ 13,762 Items Impacting Comparability: Asset Impairments — 44 960 41 — — 1,045 Transaction Gains/Losses — — — — — 59 59 Restructuring — — — — — 97 97 Other Items 37 45 (120) 28 — 60 50 Certain Tax Matters — — — — — — — Comparable (Non-GAAP) $ 4,335 $ 3,831 $ 5,910 $ 2,111 $ 426 $ (1,600) $ 15,013 Year Ended December 31, 2024 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Consolidated Reported (GAAP) $ 4,255 $ 3,792 $ 4,556 $ 2,156 $ 496 $ (5,263) $ 9,992 Items Impacting Comparability: Asset Impairments — 126 760 — — — 886 Transaction Gains/Losses — — — — — 3,118 3,118 Restructuring — — — — — 133 133 Other Items (48) (46) 56 (58) 1 27 (68) Certain Tax Matters 3 — — — — 21 24 Comparable (Non-GAAP) $ 4,210 $ 3,872 $ 5,372 $ 2,098 $ 497 $ (1,964) $ 14,085 EMEA Latin America North America Asia Pacific Bottling Investments Corporate Consolidated % Change — Reported (GAAP) 1 (1) 11 (5) (14) 66 38 % Currency Impact (5) (21) (1) (8) (2) 0 (12) % Change — Currency Neutral (Non-GAAP) 6 19 12 2 (12) 65 50 % Impact of Items Impacting Comparability (Non-GAAP) (2) 0 1 (6) 0 47 31 % Change — Comparable (Non-GAAP) 3 (1) 10 1 (14) 19 7 % Comparable Currency Impact (Non-GAAP) (4) (18) 0 (4) (2) 1 (7) % Change — Comparable Currency Neutral (Non-GAAP) 7 17 10 5 (12) 18 13 Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided. 28 -- 14 of 15 -- THE COCA-COLA COMPANY AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Financial Measures Operating Margin: Three Months Ended December 31, 2025 Three Months Ended December 31, 2024 Basis Point Growth (Decline) Reported Operating Margin (GAAP) 15.57 % 23.47 % (790) Items Impacting Comparability (Non-GAAP) (8.87) % (0.49) % Comparable Operating Margin (Non-GAAP) 24.44 % 23.96 % 48 Comparable Currency Impact (Non-GAAP) (1.71) % 0.00 % Comparable Currency Neutral Operating Margin (Non-GAAP) 26.15 % 23.96 % 219 Impact of Acquisitions and Divestitures on Comparable Currency Neutral Operating Margin (Non-GAAP) 0.00 % (0.12) % Underlying Operating Margin (Non-GAAP) 26.15 % 24.08 % 207 Year Ended December 31, 2025 Year Ended December 31, 2024 Basis Point Growth (Decline) Reported Operating Margin (GAAP) 28.71 % 21.23 % 748 Items Impacting Comparability (Non-GAAP) (2.53) % (8.80) % Comparable Operating Margin (Non-GAAP) 31.24 % 30.03 % 121 Comparable Currency Impact (Non-GAAP) (1.38) % 0.00 % Comparable Currency Neutral Operating Margin (Non-GAAP) 32.62 % 30.03 % 259 Impact of Acquisitions and Divestitures on Comparable Currency Neutral Operating Margin (Non-GAAP) 0.01 % (0.06) % Underlying Operating Margin (Non-GAAP) 32.61 % 30.09 % 252 Free Cash Flow (In millions): Year Ended December 31, 2025 Net Cash Provided by (Used in) Operating Activities (GAAP) $ 7,408 Purchases of Property, Plant and Equipment (GAAP) (2,112) Free Cash Flow (Non-GAAP) 5,296 Plus: fairlife Contingent Consideration Payment 6,069 Free Cash Flow Excluding the fairlife Contingent Consideration Payment (Non-GAAP) $ 11,365 Net Share Repurchases (In millions): Year Ended December 31, 2025 Issuances of Stock (GAAP) $ 313 Purchases of Stock for Treasury (GAAP) (746) Net Share Repurchases (Non-GAAP) $ (433) Projected 2026 Free Cash Flow (In billions): Year Ending December 31, 2026 Projected GAAP Net Cash Provided by Operating Activities $ 14.4 Projected GAAP Purchases of Property, Plant and Equipment (2.2) Projected Free Cash Flow (Non-GAAP) $ 12.2 29 -- 15 of 15 --